National Chlamydia Laboratory Committee
The National Chlamydia Laboratory Committee (NCLC) was created in 1995 by laboratory members of the CDC National Infertility Prevention Project (IPP) in conjunction with the Centers for Disease Control and Prevention (CDC) to provide a forum for the laboratory subcommittees of the ten Regional Infertility Advisory Groups to discuss issues and concerns regarding chlamydia screening tests and to develop a common position acceptable to the Regions.
Many of the issues and concerns relating to Chlamydia trachomatis laboratory testing and quality assurance are common among the ten Regional Infertility Advisory Groups and can be more effectively addressed by the combined effort of the National Chlamydia Laboratory Committee members.
Several issues regarding chlamydia testing have been under discussion by the NCLC and recommendations proposed based on experience of the Committee members and a review of the scientific literature. Those issues on which the NCLC has reached a consensus are now available on-line to provide ready access for city, county, and state public health laboratories as well as other Infertility Prevention Project partners, the scientific and medical community.
Recommendations
-
Single Use Devices for Point-of-Care Chlamydia Tests
-
Specimen Rejection Criteria
-
Quality Assurance of Chlamydia Testing Laboratories
-
Persistence of Chlamydia DNA and Chlamydia Antigens after Therapy
-
Negative Grey Zone Supplemental Testing to Enhance Sensitivity on Non-Amplification Tests
-
Inhibition of Ampification in DNA Amplification Assays for Chlamydia trachomatis
-
Chlamydia Screening Algorithms
-
Practical Guidelines for Chlamydia Test Verification (3/2001)
For any questions regarding these recommendations, please contact:
Richard Steece, Ph.D.,D(ABMM)
National Chlamydia Laboratory Coordinator
CDC Infertility Prevention Project
1811 Flag Mountain Drive
Pierre, South Dakota 57501
Office/Fax: (605) 224-9240
DrRSteece@aol.com
